Miriam is Head of Regulatory Affairs at Immatics and oversees strategic and operational RA for Immatics’ cellular and bispecific product pipeline as well as for companion diagnostics.

She brings 20 years of experience in Regulatory Affairs for oncology and generic drugs. Miriam holds a PhD from her work at the Max-Planck-Institute for Biochemistry in Munich and a Master of Drug Regulatory Affairs.